Uganda and Kenya are among nine African countries to have received initial doses of the HIV drug Nairobi, Kenya | AGENCIES | Demand for a twice-yearly HIV prevention injection is outpacing supply in ...
Ralinepag works by restoring prostacyclin signaling and activating prostacyclin receptors to affect pathways that play a role in the progression of PAH. The drug was originally formulated as an ...
Biomedical engineers at Duke University have developed a new approach to delivering GLP-1 medications orally that does not ...
We cannot waste this once-in-a-generation HIV breakthrough – it must reach the young women who need it most - COMMENT: The lenacapavir jab removes the burden of daily pills, Philippe Duneton and Anne ...
Benue State launches Lenacapavir, a twice-yearly injectable for HIV prevention, to combat its high prevalence rate and help ...
3 Blue-Chip Stocks Built for a Rotating Market Gilead Sciences (NASDAQ:GILD) Chief Commercial Officer and Head of Corporate Affairs Johanna Mercier said the company is leaning on its HIV business ...
MarketBeat on MSN
Gilead Sciences Highlights Trodelvy Lung Data, Long-Acting HIV Pipeline at RBC Conference
3 Blue-Chip Stocks Built for a Rotating Market Gilead Sciences (NASDAQ:GILD) Chief Medical Officer Dietmar Berger outlined several upcoming clinical and regulatory priorities across oncology, ...
Low PrEP uptake is slowing France’s HIV prevention goals, with major gaps in access for key groups. Learn more.
Independent Newspaper Nigeria on MSN
Nigeria pushes towards zero HIV transmission goal, holds nationwide training on lenacapavir rollout
LAGOS Nigerians living with HIV who achieve virological suppression can expect to live for 33 years without transmitting the virus, according to health experts, as nationwide training begins for the ...
Financial hardship correlated strongly with nonadherence, with 37.3% of nonadherent participants unable to get by financially ...
Oral sex, often seen as safe, carries medical risks including STIs – while it may have lower transmission risk than penetrative sex, it is not risk-free.
AllAfrica on MSN
Benue, With Nigeria's Heaviest HIV Treatment Burden, Launches Long-Acting Prevention Drug
The Benue State Government has launched Lenacapavir, a long-acting injectable drug for HIV prevention, as part of efforts to curb new infections and end AIDS by 2030.The Benue State Government has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results